Most Popular

A Note From Cate: 2021 Progress So Far

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (July 2021)

A Note From Cate: Looking Ahead to 2021

A quarterly note from Cate Lockhart, MS, PharmD, PhD . (March 2021)

A Note From Cate: 2020 Year-End Reflections

A quarterly note from Cate Lockhart, MS, PharmD, PhD .

Join Our Mailing List

Join Our Mailing List

BBCIC FAQs

Get answers to frequently asked questions about BBCIC.

FDA Guidance

Resources from the FDA on biosimilars.

BBCIC Resources

Resources that support BBCIC’s effort to engage data consortium, managed care specialty drug experts, researchers, and industry to monitor biosimilars.

Communications Committee

Learn about the BBCIC Communications Committee.

AMCP’s Biologics & Biosimilars Collective Intelligence Consor...

Press release: Alexandria, Va. October 27, 2015 -- (AMCP) today announced a major milestone in the formation of the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC).

Research

Explore research from the AMCP Research Institute, BBCIC and other resources.